Document is current

Article History

Received: 23 March 2022

Accepted: 7 July 2022

First Online: 16 July 2022

Declarations

:

: Updated funding for the National Pregnancy Registry for Psychiatric Medications can be found here: https://womensmentalhealth.org/research/pregnancyregistry/.Lee S. Cohen, MD (as of 3/10/2021).Research support: National Pregnancy Registry for Psychiatric Medications: Alkermes Biopharmaceuticals; Aurobindo Pharma; Auromedics Pharma LLC; Janssen Pharmaceutica; Otsuka Pharmaceuticals; Teva Pharmaceuticals; Sage Therapeutics, Inc.; Sunovion Pharmaceuticals, Inc; Supernus Pharmaceuticals.Other research support: Brain and Behavior Research Foundation; National Institute on Aging; National Institutes of Health; SAGE Therapeutics.Advisory/consulting: JDS Therapeutics LLC. As an employee of MGH, Dr. Cohen works with the MGH CTNI, which has had research funding from multiple pharmaceutical companies, including Alkermes Biopharmaceuticals and Praxis Precision Medicines, Inc., and the NIMH.Speaking/honoraria: None.Royalty/patent/other income:None.Marlene P. Freeman, MD (as of 2/4/2021).Research support: National Pregnancy Registry for Psychiatric Medications: Alkermes Biopharmaceuticals; Aurobindo Pharma; Auromedics Pharma LLC; Janssen Pharmaceutica; Otsuka Pharmaceuticals; Teva Pharmaceuticals; Sage Therapeutics, Inc.; Sunovion Pharmaceuticals, Inc; Supernus Pharmaceuticals.Other research support: SAGE Therapeutics. As an employee of MGH, Dr. Freeman works with the MGH CTNI, which has had research funding from multiple pharmaceutical companies and NIMH.Advisory/consulting: Advisory Boards: Eliem, Sage; Independent Data Safety and Monitoring Committee: Janssen (Johnson & Johnson), Novartis; Steering Committee for Educational Activities: Medscape; educational activities: WebMD.Speaking/honoraria: None.Royalty/patent/other income: None.Adele C. Viguera, MD, MPH (as of 2/10/2021).Research support: National Pregnancy Registry for Psychiatric Medications: Alkermes Biopharmaceuticals; Aurobindo Pharma; Auromedics Pharma LLC; Janssen Pharmaceutica; Otsuka Pharmaceuticals; Teva Pharmaceuticals; Sage Therapeutics, Inc.; Sunovion Pharmaceuticals, Inc; Supernus Pharmaceuticals.Other research support: SAGE Therapeutics.Advisory/consulting: Up-to-Date.Speaking/honoraria: None.Royalty/patent/other income: None.Past sponsors of National Pregnancy Registry: Forest/Actavis Pharmaceuticals (2016–2018); AstraZeneca Pharmaceuticals (2009–2014, declined to sponsor: 2014–Present); Ortho-McNeil-Janssen Pharmaceuticals, Inc (2009–2014, declined to sponsor: 2015–Present); Pfizer, Inc. (2009–2011, declined to sponsor: 2012–Present).Adele C. Viguera, MD, MPH (as of 2/10/2021).Research support: National Pregnancy Registry for Psychiatric Medications: Alkermes Biopharmaceuticals; Aurobindo Pharma; Auromedics Pharma LLC; Janssen Pharmaceutica; Otsuka Pharmaceuticals; Teva Pharmaceuticals; Sage Therapeutics, Inc.; Sunovion Pharmaceuticals, Inc; Supernus Pharmaceuticals.Other research support: SAGE Therapeutics.Advisory/consulting: up-to-date.Speaking/honoraria: None.Royalty/patent/other income: None.Past sponsors of National Pregnancy Registry: Forest/Actavis Pharmaceuticals (2016–2018); AstraZeneca Pharmaceuticals (2009–2014, declined to sponsor: 2014-Present); Ortho-McNeil-Janssen Pharmaceuticals, Inc (2009–2014, declined to sponsor: 2015-Present); Pfizer, Inc. (2009–2011, declined to sponsor: 2012-Present).Mercedes J. Szpunar, MD, PhD, Lauren A. Kobylski, MPH, Heather Harmon, MPH — Nothing to disclose.